ResearcherUtrecht UniversityNo recent work listed
Maarten Simon van Leeuwen
Matched on OpenAlex author ID A5110615478. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2018: 1 paper · 2019: 2 papers · 2020: none · 2021: 2 papers
Papers 5
- Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohort. Co-author DOI 10.1016/j.ejso.2020.11.137↗
- Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled… Co-author DOI 10.1186/s13063-021-05248-y↗
- Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study. Co-author DOI 10.1016/j.ejso.2019.06.008↗
- Added value of intra-operative ultrasound to determine the resectability of locally advanced pancreatic cancer following FOLFIRINOX chemotherapy (IMAGE): a pro… Co-author DOI 10.1016/j.hpb.2019.02.017↗
- Computed tomography findings after radiofrequency ablation in locally advanced pancreatic cancer. Last author DOI 10.1007/s00261-018-1519-y↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marieke S. Walma · 5 shared papers, 2018–2021 · strength 0.41
- Paper Computed tomography findings after radiofrequency ablation in locally advanced pancreatic cancer. DOI 10.1007/s00261-018-1519-y↗
- Paper Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study. DOI 10.1016/j.ejso.2019.06.008↗
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Izaak Quintus Molenaar · 5 shared papers, 2018–2021 · strength 0.41
- Paper Computed tomography findings after radiofrequency ablation in locally advanced pancreatic cancer. DOI 10.1007/s00261-018-1519-y↗
- Paper Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study. DOI 10.1016/j.ejso.2019.06.008↗
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Hjalmar C. van Santvoort · 5 shared papers, 2018–2021 · strength 0.41
- Paper Computed tomography findings after radiofrequency ablation in locally advanced pancreatic cancer. DOI 10.1007/s00261-018-1519-y↗
- Paper Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study. DOI 10.1016/j.ejso.2019.06.008↗
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Ignace H. J. T. de Hingh · 4 shared papers, 2019–2021 · strength 0.32
- Paper Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study. DOI 10.1016/j.ejso.2019.06.008↗
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Marc G. Besselink · 4 shared papers, 2019–2021 · strength 0.32
- Paper Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study. DOI 10.1016/j.ejso.2019.06.008↗
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Richard van Hillegersberg · 3 shared papers, 2018–2021 · strength 0.25
- Paper Computed tomography findings after radiofrequency ablation in locally advanced pancreatic cancer. DOI 10.1007/s00261-018-1519-y↗
- Paper Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study. DOI 10.1016/j.ejso.2019.06.008↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Steffi J. E. Rombouts · 3 shared papers, 2018–2021 · strength 0.25
- Paper Computed tomography findings after radiofrequency ablation in locally advanced pancreatic cancer. DOI 10.1007/s00261-018-1519-y↗
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Krijn P. van Lienden · 3 shared papers, 2019–2021 · strength 0.24
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Paper Added value of intra-operative ultrasound to determine the resectability of locally advanced pancreatic cancer followin… DOI 10.1016/j.hpb.2019.02.017↗
- Johanna W. Wilmink · 3 shared papers, 2019–2021 · strength 0.24
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Paper Added value of intra-operative ultrasound to determine the resectability of locally advanced pancreatic cancer followin… DOI 10.1016/j.hpb.2019.02.017↗
- Nadia Haj Mohammad · 3 shared papers, 2019–2021 · strength 0.24
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Paper Added value of intra-operative ultrasound to determine the resectability of locally advanced pancreatic cancer followin… DOI 10.1016/j.hpb.2019.02.017↗
- Freek D. Daams · 2 shared papers, 2021 · strength 0.16
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Gijs A. Patijn · 2 shared papers, 2021 · strength 0.16
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Martijn Ruben Meijerink · 2 shared papers, 2021 · strength 0.16
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Vincent Erwin de Meijer · 2 shared papers, 2021 · strength 0.16
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Sebastiaan Festen · 2 shared papers, 2021 · strength 0.16
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Lilly J. H. Brada · 2 shared papers, 2021 · strength 0.16
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Judith de Vos‐Geelen · 2 shared papers, 2021 · strength 0.16
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Martijn W.J. Stommel · 2 shared papers, 2021 · strength 0.16
- Paper Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicent… DOI 10.1016/j.ejso.2020.11.137↗
- Paper Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): st… DOI 10.1186/s13063-021-05248-y↗
- Samira Fegrachi · 1 shared paper, 2019 · strength 0.08
- Joost M. Klaase · 1 shared paper, 2019 · strength 0.08
- Thijs J. Schouten · 1 shared paper, 2021 · strength 0.08
- John J. Hermans · 1 shared paper, 2021 · strength 0.08
- Geert‐Jan Creemers · 1 shared paper, 2021 · strength 0.08
- Poya Ghorbani · 1 shared paper, 2021 · strength 0.08
- Geert Roeyen · 1 shared paper, 2021 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.